Search Results
Search results for "Promel Lab"
Results found for "Promel Lab"
- Re-cap of Endocrine Metabolic GPCR 2024 with the Organizers | Dr. GPCR Ecosystem
pancreatic beta cells before returning to the UK, first to her Department at UCL and then to lead a laboratory
- Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem
pharmacology at the University of Alberta and completed postdoctoral work at University College London in the laboratory
- Dr. Matthew Eddy | Dr. GPCR Ecosystem
Eddy began learning and investigating human GPCRs while training in the laboratories of Professors Raymond
- Dr. Kenneth A. Jacobson | Dr. GPCR Ecosystem
He is currently the Senior Investigator and Chief of the Molecular Recognition Section, Laboratory of
- Mark Schmeizl | Dr. GPCR Ecosystem
Strategic Partner(s) Mark Schmeizl About Mark Schmeizl Mark leverages 30 years in various life science laboratories
- Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
His laboratory now explores how β₂-adrenergic receptor signaling can be manipulated to influence metabolism
- Eurofins DiscoverX | Dr. GPCR | Dr. GPCR Ecosystem
Your Target of Interest Find Your Solutions The Human GPCRome - Obtain Your FREE Wall Poster for Your Laboratory
- Brian Arey: Discovering Signaling Bias at the FSH Receptor | Dr. GPCR Ecosystem
Arey’s laboratory discovered the first described synthetic agonists and antagonists of the FSHR and has
- Tuning GPCR System Sensitivity: Revealing True Drug Activity Through Functional Volume Control | Dr. GPCR Ecosystem
pharmacology at the University of Alberta and completed postdoctoral work at University College London in the laboratory
- Introduction to GLP-1 pharmacology| Dr. GPCR Ecosystem
Her laboratory investigates marine-derived natural products with neuroactive properties, with particular
- Debbie Hay: Class B GPCRs, RAMPs, and the Migraine Pharmacology Gap | Dr. GPCR Ecosystem
pharmacology at Imperial College London, and 17 years at the University of Auckland, where she led her own laboratory pharmacology of CGRP at CTR-RAMP1, suggest the drug may be less target-selective than its approval label
- Brendan Wilkins | Dr. GPCR Ecosystem
Brendan is now a final year PhD candidate in the Orphan Receptor Laboratory headed by Associate Professor
- Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK.
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
She is a National Heart Foundation of Australia Future Leader Fellow and runs a laboratory of 7 Ph.D.
- Dr. Caron Tribute Part 1 | Dr. GPCR Ecosystem
He and his laboratory members studied the mechanisms of action and regulation of hormones and neurotransmitters
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
He earned his PhD at MIT in the laboratory of Lawrence Stern, where he studied structure-function relationships
- Dr. Sudha Shenoy | Dr. GPCR Ecosystem
Her laboratory has continued to work on identifying the molecular mechanisms that ascribe ubiquitin code
- Eleonora Comeo: Fluorescent Ligands and the Pharmacology of Adenosine Receptors | Dr. GPCR Ecosystem
Her work integrates organic synthesis with NanoBRET, SNAP-tag labeling, confocal microscopy, and super-resolution Comeo describes the moment she saw her synthesized ligand labeling the cell membrane as one of the most We sat down to chat about GPCRs, synthesizing labeled ligands, and her unique position that allows her
















